Cytodyn Inc (CYDY)

[Bill_ENG]

Who writes these garbage PRs ?

The title:
Leronlimab 14-Week, NASH Clinical Trial Met Primary Endpoint (PDFF) and Secondary Endpoint (cT1) for Per Protocol Population in 350 mg Weekly Dose

The Body of the article contradicting the title.

Leronlimab compared to placebo also reached near significance for the secondary endpoint cT1.

In plain english that means they did not meet the secondary endpoint in CT1.

Humorous non accurate analogy.

If Nader owned an Ice Cream business.
Customer: Hey Nodder this chocolate ice cream tastes like dog poo !
Nodder response: It looks like Chocolate ! and the peanuts are real.

Customer 2: Hey Nodder, this lemon lime ice cream tastes terrible !
Nodder Response: It is genuine, my dog made all the ice cream. He is a great worker, doing a great job, always shows up. Always produces.

nuff said.

JMO